Invention Grant
US08962616B2 Heterocyclic substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
有权
杂环取代的六氢吡喃并[3,4-d] [1,3]噻嗪-2-胺化合物
![Heterocyclic substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds](/docs/US/2015-02-24/US08962616B2/abs.jpg.600x600.jpg)
- Patent Title: Heterocyclic substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
- Patent Title (中): 杂环取代的六氢吡喃并[3,4-d] [1,3]噻嗪-2-胺化合物
-
Application No.: US13886405Application Date: 2013-05-03
-
Publication No.: US08962616B2Publication Date: 2015-02-24
- Inventor: Michael Aaron Brodney , Christopher Ryan Butler , Elizabeth Mary Beck , Jennifer Elizabeth Davoren , Brian Thomas O'Neill
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent John A. Wichtowski
- Main IPC: C07D498/04
- IPC: C07D498/04 ; A61K31/541 ; C07D513/04 ; A61K31/542
![Heterocyclic substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds](/abs-image/US/2015/02/24/US08962616B2/abs.jpg.150x150.jpg)
Abstract:
Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I, as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Public/Granted literature
- US20130296308A1 Heterocyclic Substituted Hexahydropyrano[3,4-d][1,3]Thiazin-2-Amine Compounds Public/Granted day:2013-11-07
Information query
